GSA Capital Partners’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-53,334
Closed -$292K 1664
2023
Q2
$292K Buy
53,334
+14,009
+36% +$95.3K 0.03% 1065
2023
Q1
$370K Buy
+39,325
New +$434K 0.04% 899
2016
Q2
Sell
-7,884
Closed -$199K 1795
2016
Q1
$199K Sell
7,884
-9,112
-54% -$280K 0.01% 1492
2015
Q4
$551K Buy
16,996
+8,148
+92% +$305K 0.03% 1104
2015
Q3
$312K Sell
8,848
-7,259
-45% -$328K 0.02% 1348
2015
Q2
$960K Buy
16,107
+9,117
+130% +$613K 0.04% 939
2015
Q1
$545K Buy
6,990
+4,378
+168% +$339K 0.02% 1329
2014
Q4
$202K Buy
+2,612
New +$171K 0.01% 1469

Other funds holding HHS

GSA Capital Partners's HHS Position: Q3 2023 in Review

GSA Capital Partners sold out of Harte-Hanks (HHS) in Q3 2023, closing a stake of 53,334 shares — an estimated $292K sold.

GSA Capital Partners first reported a position in HHS in Q4 2014 and held it in 8 quarters. The position peaked at $960K in Q2 2015. 23 funds tracked by Wall St. Rank hold HHS as of Q3 2023.

  • GSA Capital Partners reported no remaining Harte-Hanks position as of Q3 2023 after selling out during the quarter.
  • GSA Capital Partners sold 53,334 Harte-Hanks shares in Q3 2023, an estimated $292K.
  • GSA Capital Partners first reported a position in Harte-Hanks in Q4 2014 and held it in 8 quarters.
  • GSA Capital Partners's Harte-Hanks position peaked at $960K in Q2 2015.
  • 23 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.